Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro.

Hemavathi Dhandapani Abirami Seetharaman Hascitha Jayakumar Selvaluxmy Ganeshrajah Shirley Sunder Singh Thangarajan Rajkumar Priya Ramanathan

Published in: Journal of gynecologic oncology (2021)

Our results provide evidence that cisplatin treatment may be given after autologous TLDC administration to maintain or improve a productive anti-tumor response in vaccinated patients.

Keyphrases

dendritic cells
regulatory t cells
bone marrow
end stage renal disease
newly diagnosed
stem cells
prognostic factors
combination therapy
signaling pathway
pi k akt
endoplasmic reticulum stress